Literature DB >> 11459107

Where and what visuospatial processing in adolescents with congenital hypothyroidism.

M Leneman1, L Buchanan, J Rovet.   

Abstract

Visuospatial processing is accomplished in distinct neuroanatomic pathways. One such pathway, known as the where pathway, involves a dorsal route through magnocellular thalamic cells to occipital and parietal cortices and conveys location and motion information. A second pathway, known as the what pathway, involves a ventral route through parvocellular thalamic cells to occipital and temporal cortices and conveys color and form information. The where pathway is thought to be responsible for processing spatial relationships while the what pathway is responsible for object identification. Children with early-treated congenital hypothyroidism (CH) who exhibit selective visuospatial deficits may provide a good model to study the differential development of these pathways. Because children with CH lacked thyroid hormone at a time when needed by developing brain regions such as the parietal cortex, these children may be affected to a greater degree on tasks tapping where but not what pathway processing. We tested this hypothesis via retrospective analysis of their performance on 6 spatial tasks. Compared were 49 adolescents with CH and 49 matched control participants. On the basis of confirmatory factor analysis, tasks were assigned to either where or that pathway groupings. A repeated measures ANOVA showed the CH group was impaired relative to a normal comparison group only on where pathway tasks. Regression analyses indicated that severity of early hypothyroidism was the strongest predictor of where pathway processing but had no effect on what pathway tasks. It is concluded that thyroid hormone is required during late gestation and early life for the normal development of the where aspects of visuospatial processing.

Entities:  

Mesh:

Year:  2001        PMID: 11459107     DOI: 10.1017/s1355617701755038

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  5 in total

1.  Congenital hypothyroidism: no adverse effects of high dose thyroxine treatment on adult memory, attention, and behaviour.

Authors:  B Oerbeck; K Sundet; B F Kase; S Heyerdahl
Journal:  Arch Dis Child       Date:  2005-02       Impact factor: 3.791

Review 2.  A model of the development of the brain as a construct of the thyroid system.

Authors:  Kembra L Howdeshell
Journal:  Environ Health Perspect       Date:  2002-06       Impact factor: 9.031

Review 3.  Thyroid hormone, brain development, and the environment.

Authors:  Thomas R Zoeller; Amy L S Dowling; Carolyn T A Herzig; Eric A Iannacone; Kelly J Gauger; Ruby Bansal
Journal:  Environ Health Perspect       Date:  2002-06       Impact factor: 9.031

Review 4.  Neuropsychological Alterations in Patients with Congenital Hypothyroidism Treated with Levothyroxine: Linked Factors and Thyroid Hormone Hyposensitivity.

Authors:  Karla Cristina Razón-Hernández; Norma Osnaya-Brizuela; Armando Valenzuela-Peraza; Esperanza Ontiveros-Mendoza; Luis Miguel Rodríguez-Serrano; Jorge Pacheco-Rosado; Gerardo Barragán-Mejía; Karla Sánchez-Huerta
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

5.  Health- related quality of life and self-worth in 10-year old children with congenital hypothyroidism diagnosed by neonatal screening.

Authors:  Liesbeth van der Sluijs Veer; Marlies Je Kempers; Heleen Maurice-Stam; Bob F Last; Tom Vulsma; Martha A Grootenhuis
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2012-10-03       Impact factor: 3.033

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.